chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 11-NOV-2014 the patient was vaccinated with a dose of ZOSTAVAX dose and route unspecified (lot # J001697) that expired on 08-MAY-2014. No adverse effects reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patient of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported 2-5, units not reported) of unknown gender. On 29-SEP-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site induration, Injection site mass
Clinical narrative: This spontaneous report was received from a pharmacist via company representative and refers to two patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions and allergies were not reported. On an unknown date, the patients were vaccinated with ZOSTAVAX (dose, route of administration, anatomical location, lot# and exp. date were not provided). On an unknown date, the patients experienced hard lump at the injection site. The patients sought medical attention, they called the pharmacy. The outcomes of the event were not reported. The relatedness between vaccination and ZOSTAVAX and the event of hard lump at the injection site was not reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site induration, Injection site mass
Clinical narrative: This spontaneous report was received from a pharmacist via company representative and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose, route of administration, anatomical location, lot# and exp. date were not reported). On an unknown date, the patient experienced hard lump at the injection site, it was reported that the hard lump started at the injection site but moved toward the inner part of the patient's arm (the date was not reported). The patient sought medical attention and called the pharmacy. The outcome of the events was not reported. The relatedness between vaccination with PNEUMOVAX 23 and the events was not reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a health worker on 05-NOV-2014 refers to an unspecified 12 month old patient. The patient inadvertently received 2 doses of VARIVAX injection (strength, dose, route and lot# were unknown) on an unspecified date of 2014 within the last week. No adverse effect reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some times to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 13-18, units not reported) of unknown gender. On 29-SEP-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some times to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 01-OCT-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some times to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 13-18, units not reported) of unknown gender. On 23-SEP-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Age: 40.0
Sex: U
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: This spontaneous report as received from a pharmacist via company representative refers to a patient of unknown gender and of about 40 year old (reported as "about age 40 years"). On unspecified date in 1994 (also reported as "20 years ago"), the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot # were not reported). There were no concomitant medications. No adverse effect were reported. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age. 3 unspecified patients were vaccinated with PROQUAD (Merck) 0.5ml subcutaneously, lot # J006569, expiration date 30-NOV-2014. 2 patients received doses on 02-DEC-2013 and 1 patient received a dose on 08-AUG-2014. The patients received doses of PROQUAD (Merck) but were supposed to receive M-M-R II. The doses of PROQUAD (Merck) that were administered were exposed to temperature outside of the proper storage range. No adverse effects were reported. Follow up information has been received from a nurse. It was reported that on an unspecified date 5 doses of improperly stored PROQUAD (Merck) were administered to unknown number of patients on an unknown dates. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with (Oka/Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers not route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Oka/Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 13-18, units not reported) of unknown gender. On 19-SEP-2014, the patient was vaccinated with (Oka/Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route not were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a pharmacist via company representative refers to a male patient of unknown age. The patient's concomitant conditions and medical history were not reported. On an unknown date, reported as several years ago, the patient was vaccinated ZOSTAVAX (dose, route of administration, anatomical location, lot #, expiration date were not reported) as vaccination to prevent shingles. Concomitant medications were not reported. On an unknown date, after receiving the vaccination with ZOSTAVAX, the patient developed shingles. The outcome of shingles was unknown. The relatedness between the event and the vaccination with ZOSTAVAX was not provided. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a health worker on 03-NOV-2014 refers to a patient of unknown age and gender. On 30-OCT-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot # J008802, expiration date: 19-OCT-2014, strength, dose and route were unknown). The ZOSTAVAX did not have any previous temperature excursions. The ZOSTAVAX was supported with post-expiry data. No adverse symptoms reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX (Merck) which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the VARIVAX (Merck) information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 24-SEP-2014, the patient was vaccinated with a dose of VARIVAX (Merck) which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some times to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 16-SEP-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a pharmacist via company representative refers to a female patient of unknown age. On an unknown date in 1979 the patient was vaccinated with a dose of ZOSTAVAX dose and route unspecified (lot# was not provided). On an unknown dates the patient has developed shingles six times since receiving ZOSTAVAX in 1979. The outcome of the event was unknown. Relatedness between the event and ZOSTAVAX was not provided. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with (Oka/Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Oka/Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates and vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 17-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a physician refers to a 1 year old patient of unknown gender. On 27-FEB-2014, the patient was subcutaneously vaccinated with dose of MMR II, HSA, 0.5 ml (lot#, expiration date, anatomical location were not reported). On 10-JUN-2014, the patient was subcutaneously vaccinated with dose of MMR II, HSA, 0.5 ml (lot#, expiration date, anatomical location were not reported). No adverse experience was reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patient were vaccinated with (Oka/Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Oka/Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 25-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX which were improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Sex: F
Vaccine: PPV
Symptoms: Cough, Erythema, Pyrexia
Clinical narrative: This spontaneous report as received from a female patient of unknown age refers to herself. On 10-NOV-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 dose and route unspecified (lot # K007826, expiration date: 03-FEB-2016). On 10-NOV-2014 the patient experienced fever, coughing (extreme coughing), possibly cellulitis and redness from the shoulder down her arm past her elbow. The patient sought medical attention, she called pharmacist. The outcome of the events was reported as not recovered/not resolved. Relatedness between the events and PNEUMOVAX 23 was not provided. Additional information is not expected, because there are no reporter's contact details.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some times to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 25-SEP-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Musculoskeletal pain, Swelling
Clinical narrative: This spontaneous report as received from a medical assistant via a company representative refers to a 65 year old female patient with diabetes. On an unknown date, as recommended because she was a diabetic, the patient was vaccinated with her second dose of PNEUMOVAX 23 (lot#, expiry date and dose were not provided) "as indicated" via intramuscular (IM) injection. Since getting her second dose of the vaccination, the patient reported that she had swelling and shoulder pain. The outcome of the events was not provided. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker (office manager) via a company representative refers to an 8 years and 10 months old male patient. On an unknown date, the 8 years and 10 months old patient was vaccinated with a first dose of GARDASIL (exact dose, route, lot# and expiration date were not reported). No adverse effects were reported. No PQC (product quality complaint) was reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated subcutaneously with a dose of VARIVAX (0.5 ml, lot# and expiration date were not reported) after that vaccine was exposed to a temperature excursion of 12 degrees F for 1 hour. No adverse effect was reported. No PQC (product quality complaint) was reported. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes ophthalmic
Clinical narrative: Pt has VAERS #1301USA010586 from vaccination 01/17/2013.
Age: 36.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Asthenia, Hypoaesthesia, Mobility decreased, Pain
Clinical narrative: My shoulder was extremely sore and has gotten worse. I have no strength in my arm, numbness, and limited range of motion. I have visited my primary care doctor and have been on Naproxen for 2 weeks with very little relief. I was referred to a muscle specialist now and I am waiting for that appointment which I believe will lead to an MRI.
Age: 36.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Asthenia, Hypoaesthesia, Joint range of motion decreased, Musculoskeletal pain
Clinical narrative: My shoulder was extremely sore and has gotten worse. I have no strength in my arm, numbness, and limited range of motion. I have visited my primary care doctor and have been on Naproxen for 2 weeks with very little relief. I was referred to a muscle specialist now and I am waiting for that appointment which I believe will lead to an MRI.
Age: 38.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Back pain, Blister, Musculoskeletal pain, Rash erythematous
Clinical narrative: Woke up with severe back and shoulder pain. Then as the day grew older this red raised rash started to develop. By the evening it had popped up all these tiny blisters.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Patient was given vaccination to the left arm via intramuscular. She states that the area began to feel itchy and warm to touch. The injection site was made visible by a small bump.
Age: 57.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Dizziness, Presyncope
Clinical narrative: Extreme weakness, dizziness.  Nearly fainted.
Age: 43.0
Sex: F
Vaccine: UNK
Symptoms: Eyelid oedema, Respiratory tract congestion, Swelling face, Throat irritation
Clinical narrative: Itchy throat, facial swelling, congestion, facial swelling increased overnight with eyes swollen shut morning of 11/16/2014.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Rash
Clinical narrative: High grade fever. Rash on lower torso.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Pyrexia
Clinical narrative: Fever up to 103, chills, cough.
Age: 3.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site erythema, Injection site pruritus, Pyrexia, Rash
Clinical narrative: Fever of 101.5, rash on bottom and red itchy where shot was administered.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Nuclear magnetic resonance imaging brain, VIth nerve paralysis
Clinical narrative: Left 6th nerve palsy, lasted 7-10 days.
Age: 18.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Grand mal convulsion
Clinical narrative: Grand mal seizure.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Muscle disorder
Clinical narrative: CANNOT LIFT OUT OF SEATING POSTION, MUSCLE WILL NOT WORK.
Age: 69.0
Sex: F
Vaccine: TDAP
Symptoms: Musculoskeletal pain, Nail disorder
Clinical narrative: Pt stated she felt fine after the injection (injection site- left upper arm 11/3/2014).  Went to chiropractor on 11/14/14 and her right shoulder blade is hurting on  11/15/14. I did notice patient had soilin her nails and asked if patient did any yard work.  She denied any yard work but stated if may be the result of the tdap shot.
Age: 38.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site bruising
Clinical narrative: Bruising at the injection site that lasted 2 weeks after administration.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Dermatitis allergic, Dizziness, Feeling abnormal, Hot flush, Neuropathy peripheral
Clinical narrative: Itchy and tingling skin, which later turned into allergic rash on arms, neck, chest and back. Later symptoms of dizziness, brain fog, neuropathy, hot flashes.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Pruritus, Rash
Clinical narrative: Itchy and tingling skin, which later turned into allergic rash on arms, neck, chest and back. Later symptoms of dizziness, brain fog, neuropathy, hot flashes.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Fatigue, Influenza like illness, Injection site erythema, Injection site swelling
Clinical narrative: 3 inch red and 3 inch swollen injection site. Body aches everywhere, extreme fatigue and weakness, fever 99.5 and flu like symptoms. I have never had a reaction before to any vaccines in past. I'm still sick and it is 11/16/14.  Called MD and he RXed antibiotics.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: 3 inch red and 3 inch swollen injection site. Body aches everywhere, extreme fatigue and weakness, fever 99.5 and flu like symptoms. I have never had a reaction before to any vaccines in past. I'm still sick and it is 11/16/14.  Called MD and he RXed antibiotics.
Age: 73.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Rash, Rash pruritic
Clinical narrative: Patient received both the Pneumovax (right arm) and flu shot (left arm) on 11/13/14.  She called the pharmacy 11/15/14 in the am complaining of bumps and what appears to be a rash on her right arm.  She called once again on 11/16 to report that her left arm now had the rash, but was not as severe as the right arm.  She also states that it is itchy.  No swelling reported.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Pain exists from injection site down to elbow.
Age: 34.0
Sex: F
Vaccine: FLUX
Symptoms: Myalgia, Pain, Pain in extremity, Tenderness
Clinical narrative: Muscle pain that continues even today, one month post injection. Unable to lay on my left arm and painful to raise left arm.
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Swelling, pain, redness, itching at injection site.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Capillary nail refill test, Hypoaesthesia, Injection site bruising, Injection site erythema, Injection site swelling
Clinical narrative: The patient presented to the clinic with redness below the injection and swelling of the left upper extremity. The left arm (which was affected)measured 40.5cm and the right upper arm measured 36.5 in circumfrence. The patient complained of numbness and tingling down his left arm. The medial and ulnar surfaces were numb, per the patient. He did not complain of pain. Cap refill was less than 2 seconds. The patient had full range of motion. The injection site was slightly bruised.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Laboratory test normal, Paraesthesia
Clinical narrative: The patient presented to the clinic with redness below the injection and swelling of the left upper extremity. The left arm (which was affected)measured 40.5cm and the right upper arm measured 36.5 in circumfrence. The patient complained of numbness and tingling down his left arm. The medial and ulnar surfaces were numb, per the patient. He did not complain of pain. Cap refill was less than 2 seconds. The patient had full range of motion. The injection site was slightly bruised.
Age: 2.0
Sex: F
Vaccine: DTAPIPVHIB, FLUN4, HEPA
Symptoms: Abnormal behaviour, Pyrexia
Clinical narrative: Temp 101, "not herself" within 24 hours of Flumist. Then had fever off and on every day until 10/23/14.
Age: 7.0
Sex: F
Vaccine: FLU4
Symptoms: Oropharyngeal pain, Pyrexia, Streptococcus test negative, Vomiting
Clinical narrative: Started with fever and vomting within 24 hours of getting vaccine and then started with sore throat. At 48 hours, temp 102.6 fever did not resolve until 10/21/14.
Age: 0.61
Sex: M
Vaccine: DTAPHEPBIP, FLU4, HIBV
Symptoms: Irritability, Otitis media, Pyrexia
Clinical narrative: 2 days after vaccine developed fiver and fussiness, refusing to eat - brought to walk in and dxd with otitis media.
Age: 60.0
Sex: M
Vaccine: FLU3
Symptoms: Cellulitis
Clinical narrative: Left elevated arm - x lrg amt cellulitis, Sta A minor - notice upon waking, elevated thru day.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Neuralgia
Clinical narrative: Patient claims vaccine was administered too high on arm and is now suffering from nerve pain.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU4, IPV, MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: 13x7 cm area of localized induration, mild tenderness L ant thigh. 2x3 cm area mild erythemia R thigh.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Rash on face, arms, started 11/11/14 in the morning at approximately 6 AM. Went to Dr was put on steriod Prednisone for 6 days.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Pruritus, Throat irritation
Clinical narrative: Patient reported to public health nurse on 11/14/14 that she had to take herself to medical center on 11/10/14 at 6:00 PM because of symptoms of shortness of breath, itching on arms, legs, torso and throat. she was treated at medical center with 1x BENADRYL-50ml IV, 1x BACTRIM IV and prednisone 20mg x 6 days.
Age: 36.0
Sex: F
Vaccine: FLUN4
Symptoms: CSF test normal, Headache, Nausea, Neck pain
Clinical narrative: Two days following FLUMIST pt c/o HA every morning. On 11/11/14 patient woke with HA, neck pain et nausea. Presented to physician's office et sent to E.R. Admitted with possible viral meningitis, CD-1 form sent to HD. Recent vaccination noted on admit.
Age: 16.0
Sex: M
Vaccine: FLU3, HEPA, HPV4, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Right arm redness, swelling, and pain; 8 cm red, raised patch on right deltoid.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, FLU3, MMRV
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 11x13 cm area of redness and warmth, pain, right thigh.
Age: 60.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Full blood count, Hot flush, Local swelling, Metabolic function test, Urine analysis
Clinical narrative: Leg swelling x 10 days. Hot flashes x 10 days.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Pt with approx 2.5" circle of induration and erythema on L thigh at site of injection. No rash/fever. Ice and age appropriate IBU suggested.
Age: 6.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site swelling
Clinical narrative: L arm localized swelling around injection site. Treated with Benadryl, Tylenol and cool compresses.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Headache, Paraesthesia, Skin warm, Swelling face
Clinical narrative: Face swelling, tingling, hot red face, headache. Treated with Prednisone and Benadryl.
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Adverse event following immunisation
Clinical narrative: Could not contact patient/unknown
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Aphagia, Hypersensitivity, Pharyngeal oedema, Pruritus generalised, Rash generalised
Clinical narrative: Could not contact patient/unknown
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Chills, Pyrexia
Clinical narrative: Pt called an stated that she had chills 2 hrs after getting flu shot and had aching in her hip replacement. Today, 11/15/14, the patient has a fever of 100.4 degrees and will be going to a health clinic to determine if she has the flu.
Age: 36.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Grip strength decreased, Injected limb mobility decreased
Clinical narrative: Pt complained of non ROM, can not grip with right hand, cannot bend at the elbow.
Age: 50.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Erythema, Pruritus, Skin warm
Clinical narrative: Red on entire back of upper arm, itchy, hot/warm to touch. Started 11/11/14 got gradually worse.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Influenza like illness, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient came in today on 11/15 and told me about her symptoms she had when she got her flu shot on 11/1. She experienced redness, swelling, pain at injection site and later had flu-like symptoms of fever, congestion, nausea and fatigue which she said lasted 5 days. No treatment from Dr was sought out.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Pyrexia, Respiratory tract congestion
Clinical narrative: Patient came in today on 11/15 and told me about her symptoms she had when she got her flu shot on 11/1. She experienced redness, swelling, pain at injection site and later had flu-like symptoms of fever, congestion, nausea and fatigue which she said lasted 5 days. No treatment from Dr was sought out.
Age: 90.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Chills, Feeling cold, Pain in extremity
Clinical narrative: Pt received flu shot and PREVNAR13 (separate arms) at approx. 2:53 PM. Pt said she went out to dinner that night and about 8 PM when she was sitting, she suddenly felt her legs to be really sore, and after dinner she said she was very cold and shivering. In the next AM she was back to being normal. Pt came into to Rx today 11/15/14 to pick up med's and reported these side effects.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Lacrimation increased, Rash, Respiratory tract congestion, Swelling face
Clinical narrative: Per patient 2 hours after shot severe swelling of face, coughing, watery eyes. Called pharmacy at 5:28 (personnel took the call) then called back to ask what to do complained at that time of cough/some swelling told to go to ER. She went and got better but claims to be having a continuing rxn. Says she has coughing/congestion when she is off prednisone. She says a rash/hives did develop.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Per patient 2 hours after shot severe swelling of face, coughing, watery eyes. Called pharmacy at 5:28 (personnel took the call) then called back to ask what to do complained at that time of cough/some swelling told to go to ER. She went and got better but claims to be having a continuing rxn. Says she has coughing/congestion when she is off prednisone. She says a rash/hives did develop.
Age: 80.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Local swelling, Skin warm
Clinical narrative: Pt had a very red, hot, and swollen arm after receiving the vaccination. Went to an urgent care MD. He told her to take Benadryl.
Age: 58.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Mobility decreased, Neck pain
Clinical narrative: Very bad headache, stabbing pain in neck, could not move head side to side or up and down.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Fatigue, Hyperhidrosis, Hypersomnia, Nausea
Clinical narrative: Patient received vaccine around 3:45 pm. Around 1 am, patient experienced profuse sweating and chills, nausea and tiredness. He also stated his arm was sore. He stated he slept for 14 hours and was still tired today (11/14/14).
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Patient received vaccine around 3:45 pm. Around 1 am, patient experienced profuse sweating and chills, nausea and tiredness. He also stated his arm was sore. He stated he slept for 14 hours and was still tired today (11/14/14).
Age: 64.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Nausea, Pain in extremity, Pyrexia, Swelling, Vomiting
Clinical narrative: Fever 103 degrees. Severe pain in arm. Swelling. Nausea, vomiting.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Paraesthesia
Clinical narrative: Soreness after administration followed by extreme pain, soreness, and tingling one week after vaccination.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injection site erythema, Injection site swelling, Local swelling
Clinical narrative: Patient with redness, swelling from injection site to mid forearm. Given BENADRYL 50 mg by mouth and ice packs, and swelling/redness improved.
Age: 58.0
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Cellulitis, Local swelling, Rash, Skin warm
Clinical narrative: Rash on her right side. Hot to touch. Spread around her arm to the elbow. Her hand was swollen. She was treated for cellulitis.
Age: 0.67
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Pyrexia
Clinical narrative: Fever 102 less than 12 hours after vaccines.
Age: 6.0
Sex: M
Vaccine: FLUN4
Symptoms: Blood urine present, Chest X-ray abnormal, Cough, Full blood count normal, Malaise
Clinical narrative: 10/30 - seen for fever of 102 and 1 week of cough told post vaccine fever. 10/31 - seen for fever, worse sxs and cough, mom reports to walk in provider he was sick x 2 weeks.
Age: 6.0
Sex: M
Vaccine: FLUN4
Symptoms: Pyrexia, Streptococcus test positive, Urine ketone body present
Clinical narrative: 10/30 - seen for fever of 102 and 1 week of cough told post vaccine fever. 10/31 - seen for fever, worse sxs and cough, mom reports to walk in provider he was sick x 2 weeks.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Anaphylactic shock
Clinical narrative: Approximately 5 hours after receiving vaccine patient in to anaphylactic shock and was taken to the E.R.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a other health professional (nurse) refers to a patient of unknown demographics. Patient's pertinent medical history and drug allergies were not reported. On 13-NOV-2014 the patient was administered improperly stored PROQUAD, .5 ml, subcutaneous (lot # and expiry date unknown). No adverse effects were reported. No product quality complaint (PQC) was reported. Causality assessment was reported as not related to therapy with PROQUAD. This case is related to MARRS# 1411USA004937. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a other health professional (nurse) refers to a patient of unknown demographics. Patient's pertinent medical history and drug allergies were not reported. On 10-NOV-2014 the patient was inadvertently administered PROQUAD (Merck), .5 ml, subcutaneous (lot # and expiry date unknown) that had been improperly stored. No concomitant therapies were reported. No adverse effects were reported. No product quality complaint (PQC) was reported. Causality assessment was reported as not related to therapy with PROQUAD (Merck). This case is related to MARRS # 1411USA007073. Additional information has been requested.
Sex: M
Vaccine: PPV
Symptoms: Peripheral swelling
Clinical narrative: Pt's arm swollen from shoulder to elbow, received antibiotic and steroid from ER.
Age: 64.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site swelling
Clinical narrative: Patient reported that she had experienced redness and inflammation and swelling at the injection site. She stated that the spot was the size of a half-dollar. She reported that she took BENADRYL and her symptoms improved. The patient made this report to the pharmacy by telephone on 11/16/14 at 4:30 pm.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old female patient with unspecified nodular cancer. The patient had no drug reactions/allergies. On 21-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 (lot#, dose, dose# and route unspecified). Almost immediately after the vaccination the patient experienced a "severe injection site reaction accompanied by fever and malaise" on 21-OCT-2014. Pharmacist reported that the injection site was "warm to the touch and swollen with erythema". Pharmacist stated "it looked like cellulitis". Pharmacist referred the patient to her unspecified physician who prescribed an unspecified antibiotic for treatment. Pharmacist reported that the patient came back to the pharmacy "about a week later" and the reaction site was "going down but still present" and the patient still felt malaise. No lab diagnostics were performed. The outcome of the event "cellulitis/ severe injection site reaction accompanied by fever/injection site was warm to the touch and swollen with erythema" was recovering/resolving. The outcome of the event malaise was not recovered. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Malaise, Pyrexia
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old female patient with unspecified nodular cancer. The patient had no drug reactions/allergies. On 21-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 (lot#, dose, dose# and route unspecified). Almost immediately after the vaccination the patient experienced a "severe injection site reaction accompanied by fever and malaise" on 21-OCT-2014. Pharmacist reported that the injection site was "warm to the touch and swollen with erythema". Pharmacist stated "it looked like cellulitis". Pharmacist referred the patient to her unspecified physician who prescribed an unspecified antibiotic for treatment. Pharmacist reported that the patient came back to the pharmacy "about a week later" and the reaction site was "going down but still present" and the patient still felt malaise. No lab diagnostics were performed. The outcome of the event "cellulitis/ severe injection site reaction accompanied by fever/injection site was warm to the touch and swollen with erythema" was recovering/resolving. The outcome of the event malaise was not recovered. Additional information has been requested.
Age: 1.09
Sex: F
Vaccine: HEPA, MMR, VARCEL, HEPA, MMR, VARCEL
Symptoms: Blood test, Blood urine present, Haemorrhage subcutaneous, Rash generalised
Clinical narrative: Child received MMR, varicella and Hep A #1 on 29 Apr '14. She had no immediate adverse reactions to the vaccination. However on day 8 post vaccine (7 May), the child ran a fever to 102.6 and developed a rash on her arms and legs. By the next day the rash had spread to her back, sides, ears, stomach and face. Her appetite was diminished, she was "clingy", she could not walk because her ankle and feet pain and mother noticed a broken blood vessel behind the right knee. She was taken to the local ER and physicians were not able to make a diagnosis. She was given BENADRYL and oral steroids, which she promptly vomited. The rash seemed to be getting worse, so child was taken to another hospital the next day. The condition was diagnosed as Henoch Schonlein Purpura and 10-12 RBCs and 10-20 WBCs were found in urine. The mother was instructed to follow-up with her PCP for urine checks.
Age: 1.09
Sex: F
Vaccine: HEPA, MMR, VARCEL, HEPA, MMR, VARCEL
Symptoms: Abasia, Arthralgia, Decreased appetite, Henoch-Schonlein purpura, Injection site rash
Clinical narrative: Child received MMR, varicella and Hep A #1 on 29 Apr '14. She had no immediate adverse reactions to the vaccination. However on day 8 post vaccine (7 May), the child ran a fever to 102.6 and developed a rash on her arms and legs. By the next day the rash had spread to her back, sides, ears, stomach and face. Her appetite was diminished, she was "clingy", she could not walk because her ankle and feet pain and mother noticed a broken blood vessel behind the right knee. She was taken to the local ER and physicians were not able to make a diagnosis. She was given BENADRYL and oral steroids, which she promptly vomited. The rash seemed to be getting worse, so child was taken to another hospital the next day. The condition was diagnosed as Henoch Schonlein Purpura and 10-12 RBCs and 10-20 WBCs were found in urine. The mother was instructed to follow-up with her PCP for urine checks.
Age: 1.09
Sex: F
Vaccine: HEPA, MMR, VARCEL, HEPA, MMR, VARCEL
Symptoms: Pain in extremity, Pyrexia, Rash generalised, Red blood cells urine positive, Vascular injury
Clinical narrative: Child received MMR, varicella and Hep A #1 on 29 Apr '14. She had no immediate adverse reactions to the vaccination. However on day 8 post vaccine (7 May), the child ran a fever to 102.6 and developed a rash on her arms and legs. By the next day the rash had spread to her back, sides, ears, stomach and face. Her appetite was diminished, she was "clingy", she could not walk because her ankle and feet pain and mother noticed a broken blood vessel behind the right knee. She was taken to the local ER and physicians were not able to make a diagnosis. She was given BENADRYL and oral steroids, which she promptly vomited. The rash seemed to be getting worse, so child was taken to another hospital the next day. The condition was diagnosed as Henoch Schonlein Purpura and 10-12 RBCs and 10-20 WBCs were found in urine. The mother was instructed to follow-up with her PCP for urine checks.